MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations

Clinically amyopathic dermatomyositis (CADM), described almost 50 years ago, is defined on the basis of still not validated criteria and characterized by skin findings almost without muscle weakness. Autoantibodies directed against the cytosolic pathogen sensor MDA5 (CADM 140) can mark this subtype...

Descripción completa

Detalles Bibliográficos
Autores principales: Parronchi, Paola, Radice, Anna, Palterer, Boaz, Liotta, Francesco, Scaletti, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637993/
https://www.ncbi.nlm.nih.gov/pubmed/26557046
http://dx.doi.org/10.1186/s12948-015-0031-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637993/
https://www.ncbi.nlm.nih.gov/pubmed/26557046
http://dx.doi.org/10.1186/s12948-015-0031-y

Ejemplares similares